.After antibody-drug conjugate (ADC) expert Seagen was actually marketed to Pfizer in 2015 for a mas...
.On the heels of a phase 3 succeed that fell short to impress real estate investors, Ironwood Pharma...
.Do not stop Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after authorizin...
.Welcome to recently's Chutes & Ladders, our roundup of considerable management hirings, firings ...
.Celebrating his company's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer called ...
.AbbVie has gone back to the resource of its antipsychotic giant Vraylar looking for an additional s...
.GenSight Biologics is weeks far from losing money. Again. The biotech merely has sufficient money t...
.Monopar Therapeutics is bouncing back a drug coming from the scrap heap of AstraZeneca's rare illne...
.Along with brand new data out on Arcus Biosciences' experimental HIF-2a inhibitor, one team of anal...
.After developing a gene therapy relationship with Dyno Therapies in 2020, Roche is back for even mo...